These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 34806478

  • 1. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
    Cui Y, Huang X, Guo J, Zhang N, Liang J, Zhang Y, Liao Y, He D.
    Technol Cancer Res Treat; 2021; 20():15330338211057982. PubMed ID: 34806478
    [Abstract] [Full Text] [Related]

  • 2. BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.
    Chen H, Song A, Wang Y, He Y, Tong J, Di J, Li C, Zhou Z, Cai X, Zhong D, Da J.
    Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
    [Abstract] [Full Text] [Related]

  • 3. Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens.
    Fu G, Chazen RS, MacMillan C, Witterick IJ.
    JAMA Netw Open; 2021 Oct 01; 4(10):e2127243. PubMed ID: 34613404
    [Abstract] [Full Text] [Related]

  • 4. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
    Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE.
    Acta Cytol; 2011 Oct 01; 55(6):576-83. PubMed ID: 22156469
    [Abstract] [Full Text] [Related]

  • 5. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.
    Diagn Cytopathol; 2015 Oct 01; 43(10):786-90. PubMed ID: 26152656
    [Abstract] [Full Text] [Related]

  • 6. BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.
    Sheng D, Yu X, Li H, Zhang M, Chen J.
    Medicine (Baltimore); 2021 Sep 17; 100(37):e27167. PubMed ID: 34664843
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
    Lan Z, Yang F, Zhang J, Lan Y, Li H, He R.
    Acta Cytol; 2023 Sep 17; 67(6):629-638. PubMed ID: 37708867
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
    Li X, Du H, Luo J, Ding W, Lai B, He J, Xu S, Zhang Y.
    J Clin Lab Anal; 2020 Nov 17; 34(11):e23458. PubMed ID: 32671901
    [Abstract] [Full Text] [Related]

  • 9. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
    Lei L, Hong Qing S, Wei L, Ma Mo Yang F, Xiao Xiang Y.
    Am Surg; 2024 Dec 17; 90(12):3209-3215. PubMed ID: 39047144
    [Abstract] [Full Text] [Related]

  • 10. BRAF mutation analysis by ARMS-PCR refines thyroid nodule management.
    Li X, Li E, Du J, Wang J, Zheng B.
    Clin Endocrinol (Oxf); 2019 Dec 17; 91(6):834-841. PubMed ID: 31441082
    [Abstract] [Full Text] [Related]

  • 11. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
    Nam SY, Han BK, Ko EY, Kang SS, Hahn SY, Hwang JY, Nam MY, Kim JW, Chung JH, Oh YL, Shin JH.
    Thyroid; 2010 Mar 17; 20(3):273-9. PubMed ID: 20187782
    [Abstract] [Full Text] [Related]

  • 12. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for diagnosis of thyroid nodules: The influence of false-positive and false-negative results.
    Zhao CK, Zheng JY, Sun LP, Xu RY, Wei Q, Xu HX.
    Cancer Med; 2019 Sep 17; 8(12):5577-5589. PubMed ID: 31397092
    [Abstract] [Full Text] [Related]

  • 13. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
    Choi SH, Baek JH, Lee JH, Choi YJ, Ha EJ, Song DE, Kim JK, Chung KW, Kim TY, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2016 Apr 17; 84(4):607-13. PubMed ID: 26215382
    [Abstract] [Full Text] [Related]

  • 14. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.
    J Clin Endocrinol Metab; 2012 Jul 17; 97(7):2299-306. PubMed ID: 22500044
    [Abstract] [Full Text] [Related]

  • 15. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
    Trimboli P, Scappaticcio L, Treglia G, Guidobaldi L, Bongiovanni M, Giovanella L.
    Endocr Pathol; 2020 Mar 17; 31(1):57-66. PubMed ID: 31811566
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
    Fnais N, Soobiah C, Al-Qahtani K, Hamid JS, Perrier L, Straus SE, Tricco AC.
    Hum Pathol; 2015 Oct 17; 46(10):1443-54. PubMed ID: 26232865
    [Abstract] [Full Text] [Related]

  • 17. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY, Shin JH, Ko EY, Han BK.
    AJR Am J Roentgenol; 2012 Apr 17; 198(4):891-5. PubMed ID: 22451557
    [Abstract] [Full Text] [Related]

  • 18. Real-life utility of five-gene panel test in preoperative thyroid fine-needle aspiration biopsy: a large cohort of 740 patients study.
    Tang J, Ma J, Xi X, Wang L, Li H, Huo S, Zhang B.
    Endocrine; 2023 Jun 17; 80(3):552-562. PubMed ID: 36542267
    [Abstract] [Full Text] [Related]

  • 19. Significance of FNAC, BRAF mutation, and intraoperative frozen section in surgical decision-making of thyroid nodules.
    Zhu Z, Su C, Chen G, Wan F, Jin M, Duan X, Wang Y, Wang G.
    Diagn Cytopathol; 2023 Jul 17; 51(7):441-448. PubMed ID: 37042168
    [Abstract] [Full Text] [Related]

  • 20. Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodules.
    Zhang YZ, Xu T, Cui D, Li X, Yao Q, Gong HY, Liu XY, Chen HH, Jiang L, Ye XH, Zhang ZH, Shen MP, Duan Y, Yang T, Wu XH.
    Sci Rep; 2015 Nov 24; 5():16927. PubMed ID: 26597052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.